| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
SAN DIEGO—This summer saw Exagen Inc., which is focused on differential diagnosis and optimizing therapeutic intervention for patients suffering from debilitating and chronic autoimmune diseases, announce a research collaboration with the University of Washington’s School of Medicine and Dr. Christian Lood, assistant professor of medicine in the Division of Rheumatology.
 
Lood studies the role of neutrophils in inflammation and autoimmunity, with an emphasis on the contribution of neutrophils to systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) pathogenesis.
 
“Neutrophils are the main immune cells in the human circulation, participating in host defense through mechanisms including production of reactive oxygen species (ROS), phagocytosis and formation of neutrophil extracellular traps (NETs), a recently identified neutrophil cell death process in which DNA is extruded together with cytoplasmic and granular content to trap and eliminate extracellular pathogens. Although beneficial from a host-pathogen perspective, exaggerated neutrophil activation and NET formation has been linked to autoimmunity, particularly in SLE and RA,” Lood explained.
 
“We are excited to be working with Dr. Lood and his research regarding neutrophils and autoimmune diseases such as SLE and RA. We believe Exagen’s support for this promising research demonstrates our commitment to the advancement of clinical solutions for these complex and lifelong diseases,” said Dr. Thierry Dervieux, chief science officer and medical director at Exagen.

Related Topics

Published In

Volume 15 - Issue 10 | October 2019

October 2019

October 2019 Issue

Loading Next Article...
Loading Next Article...
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Reliable fluid biomarkers strategies for clinical neuroscience research

Reliable fluid biomarkers strategies for clinical neuroscience research

Explore how validated fluid biomarker assays advance clinical research for neurological diseases.
Laboratorian with a white coat and blue gloves pipettes green liquid into a beaker with multicolored liquids in beakers and tubes in the blue-tinged, sterile laboratory background.

Discovering cutting-edge nitrosamine analysis in pharmaceuticals

New tools help researchers detect and manage harmful nitrosamine impurities in drugs such as monoclonal antibodies.
A starry night sky reflected over calm water, symbolizing the discovery of hidden patterns in complex systems.

Technology Guide: Spatial biology techniques

Discover essential strategies and expert insights to navigate the expanding world of spatial biology.
Drug Discovery News March 2025 Issue
Latest IssueVolume 21 • Issue 1 • March 2025

March 2025

March 2025 Issue

Explore this issue